Journal
DRUG DELIVERY
Volume 29, Issue 1, Pages 294-304Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/10717544.2022.2026535
Keywords
Miconazole nitrate; polymeric nanocapsules; polycaprolactone; lipid core nanocapsules; permeation
Categories
Ask authors/readers for more resources
This study investigated the potential of polymeric and lipid nanocapsules as carrier systems for miconazole nitrate (MN) topical delivery, showing slow biphasic release, high drug encapsulation efficiency, and improved stability. The encapsulation strategy created formulations with promising results for MN delivery. Polymeric nanocapsules demonstrated higher cell viability and antifungal activity compared to lipid nanocapsules, suggesting potential advantages in superficial and deep fungal infections.
Nanocapsules can be equated to other nanovesicular systems in which a drug is entrapped in a void containing liquid core surrounded by a coat. The objective of the present study was to investigate the potential of polymeric and lipid nanocapsules (LNCs) as innovative carrier systems for miconazole nitrate (MN) topical delivery. Polymeric nanocapsules and LNCs were prepared using emulsification/nanoprecipitation technique where the effect of poly(epsilon-caprolactone (PCL) and lipid matrix concentrations with respect to MN were assessed. The resulted nanocapsules were examined for their average particle size, zeta potential, %EE, and in vitro drug release. Optimum formulation in both polymeric and lipidic nanocapsules was further subjected to anti-fungal activity and ex vivo permeation tests. Based on the previous results, nanoencapsulation strategy into polymeric and LNCs created formulations of MN with slow biphasic release, high %EE, and improved stability, representing a good approach for the delivery of MN. PNCs were best fitted to Higuchi's diffusion while LNCs followed Baker and Lonsdale model in release kinetics. The encapsulated MN either in PNCs or LNCs showed higher cell viability in WISH amniotic cells in comparison with free MN. PNCs showed less ex vivo permeation. PNCs were accompanied by high stability and more amount drug deposition (32.2 +/- 3.52 mu g/cm(2)) than LNCs (12.7 +/- 1.52 mu g/cm(2)). The antifungal activity of the PNCs was high 19.07 mm compared to 11.4 mm for LNCs. In conclusion, PNCs may have an advantage over LNCs by offering dual action for both superficial and deep fungal infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available